Paraneoplastic cerebellar degeneration in ovarian carcinoma: Case report with review of immune modulation

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.

Original languageEnglish
Pages (from-to)1364-1367
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume18
Issue number6
DOIs
StatePublished - Nov 2008

Keywords

  • Cerebellar degeneration
  • Ovarian cancer
  • Paraneoplastic syndrome

Fingerprint

Dive into the research topics of 'Paraneoplastic cerebellar degeneration in ovarian carcinoma: Case report with review of immune modulation'. Together they form a unique fingerprint.

Cite this